A2A INTEGRATED PHARMACEUTICALS
Live / Registered — Registered (as of 01 Jun 2021)
What this means for you
Registered since 01 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88633302
- Registration number
- 6367315
- Mark type
- Word mark
- Filed
- 27 Sept 2019
- Published for opposition
- 16 Mar 2021
- Registered
- 01 Jun 2021
- Attorney of record
- Nyall Engfield
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- A2A Integrated Pharmaceuticals, LLC, Nashville, TN, US
- A2A Integrated Pharmaceuticals, LLC, Nashville, TN, US
- A2A Integrated Pharmaceuticals, LLC, Nashville, TN, US
Prosecution history
- 01 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 16 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Mar 2021 — PUBLISHED FOR OPPOSITION
- 24 Feb 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Feb 2021 — ELECTRONIC RECORD REVIEW COMPLETE
- 22 Jan 2021 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 20 Jan 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jan 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jan 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jan 2021 — ASSIGNED TO LIE
- 06 Oct 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Sept 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Sept 2020 — NON-FINAL ACTION E-MAILED
- 08 Sept 2020 — NON-FINAL ACTION WRITTEN
- 02 Sept 2020 — PREVIOUS ALLOWANCE COUNT WITHDRAWN